Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

THC Biomed Intl Ltd. (C:THC)

Business Focus: Alternative Medicine

Sector:  Healthcare Industry:  Pharmaceuticals
See Regulatory Filings on SEDAR
Company Contact
Address: Towne Centre
P.O. Box 20033
Tel: N/A
Website: N/A
Key People
John Miller
President, Chief Executive Officer, Director
Hee Jung Chun
Interim Chief Financial Officer
Business Overview
Financial Overview
For the six months ended 31 January 2022, THC Biomed Intl Ltd revenues increased 6% to C$1.7M. Net loss decreased 58% to C$1.5M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Bank charges and interest - Balancing va decrease of 31% to C$108K (expense), Depreciation and amortization - Balancin decrease of 11% to C$362K (expense).
Employees: 45 as of Jul 31, 2021
Reporting Currency: Canadian Dollars
Enterprise value: $13.48M as of Jan 31, 2022
Annual revenue (TTM): $3.87M as of Jan 31, 2022
EBITDA (TTM): -$2.85M as of Jan 31, 2022
Net annual income (TTM): -$4.27M as of Jan 31, 2022
Free cash flow (TTM): -$2.19M as of Jan 31, 2022
Net Debt Last Fiscal Year: $5.83M as of Jan 31, 2022
Shares outstanding: 163,938,556 as of Feb 3, 2022
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization